GPD2 and cancer: These results suggest that the CR group displays a better control of lipid metabolism-related inflammatory pathways, in agreement also with the observed trend for reduction of expression in additional pro-inflammatory genes like JAK1, PATRF, CXRC1, GPD2, and glycolytic genes LDHA and IRS1, which are associated to immunosuppression in cancer (46–49).